Table 1.
Treatment groups and doses.
| Groups | Descriptions | Comment |
|---|---|---|
| Control | No HeLa cells injected | Negative control to see the effects of other treatment |
| HeLa | Injected with 2 × 106 HeLa cells | Positive control to mimic cervical cancer |
| HA | Intraperitoneally injected with 1 mg/kg histamine every 3 days | Test group to study the effects of histamine on cervical cancer |
| HA + APG | Intraperitoneally injected with 1 mg/kg histamine and 100 mg/kg apigenin every 3 days | Test group to study the effects of apigenin on cervical cancer |
| HA + AZD9496 | Intraperitoneally injected with 1 mg/kg histamine and 2 mg/kg AZD9496 every 3 days | Test group to study the effects of ERα on cervical cancer |
| HA + DPN | Intraperitoneally injected with 1 mg/kg histamine and 2 mg/kg DPN every 3 days | Test group to study the effects of ERβ on cervical cancer |